Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Injection Site Reaction”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Not applicableStudy completedNCT04078087
What this trial is testing

The Effect of Body Mass Index In Relation To Menstrual Cycle Phase on Propofol Injection Pain

Who this might be right for
Injection Site ColdnessPropofol Adverse Reaction
Ain Shams University 90
Post-approval studies (Phase 4)UnknownNCT04962152
What this trial is testing

Naldebain and Video-assisted Thoracoscopic Surgery

Who this might be right for
AnalgesiaNausea and Vomiting, PostoperativeItching+2 more
Kaohsiung Medical University Chung-Ho Memorial Hospital 60
Not applicableStudy completedNCT02490943
What this trial is testing

A Pilot Study of Warm and Cold Compress to Reduce Injection Site Erythema Due to Peginterferon-beta-1a in MS

Who this might be right for
MS (Multiple Sclerosis)Erythema
Brown, Theodore R., M.D., MPH 28
Not applicableStudy completedNCT06093815
What this trial is testing

Prospective Study to Assess Tissue Responses After Injection With Biostimulatory Products

Who this might be right for
Injection Site Reaction
Merz North America, Inc. 20
Not applicableStudy completedNCT00523237
What this trial is testing

RAL-eve Study: Raltegravir Substitution Study

Who this might be right for
HIV Infections
Stanford University 14
Not applicableStudy completedNCT00972062
What this trial is testing

Herbal Therapy for Subcutaneous Injection Site Reactions in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
University of North Carolina, Charlotte 60
Post-approval studies (Phase 4)Study completedNCT00239993
What this trial is testing

Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®

Who this might be right for
Multiple Sclerosis
Teva Neuroscience, Inc. 50
Early research (Phase 1)Study completedNCT04495478
What this trial is testing

Ramucirumab (LY3009806) in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 50
Post-approval studies (Phase 4)Looking for participantsNCT07101445
What this trial is testing

Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial

Who this might be right for
Multiple Myeloma
Emory University 94
Early research (Phase 1)Study completedNCT00365781
What this trial is testing

Examination of Dermatologic Effects From Subcutaneous Injections of ISIS 113715

Who this might be right for
Type 2 Diabetes Mellitus
Ionis Pharmaceuticals, Inc. 10
Not applicableUnknownNCT05181202
What this trial is testing

Biomarkers of Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients

Who this might be right for
Liposomal Doxorubicin Induced Hypersensitivity Reaction in Breast Cancer Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 20
Not applicableStudy completedNCT01271608
What this trial is testing

Study to Evaluate the Need of Needle Change for Application of Intramuscular, Subcutaneous and Intradermal Injection.

Who this might be right for
Knowledge, Attitudes, PracticeInjection Site Reactions
Hospital M'Boi Mirim 1,240
Not applicableStudy completedNCT04369261
What this trial is testing

Observational Study of Synovian® Inj. in Patients With Osteoarthritis in the Knee

Who this might be right for
Osteoarthritis in the Knee
LG Chem 1,949
Post-approval studies (Phase 4)Study completedNCT00317941
What this trial is testing

Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Bayer 220
Post-approval studies (Phase 4)Study completedNCT03091569
What this trial is testing

Effects of Vitamin K on Redness Associated With Injection Site Reactions in Participants Treated With Plegridy

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 23
Post-approval studies (Phase 4)Study completedNCT00240032
What this trial is testing

Evaluate the Impact on Skin (Injection Site) Reactions of Taking an Antihistamine (Zyrtec®) or Placebo Prior to Daily Injections of Copaxone®.

Who this might be right for
Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 80
Post-approval studies (Phase 4)Study completedNCT05028361
What this trial is testing

Simultaneous mRNA COVID-19 and IIV4 Vaccination Study

Who this might be right for
Quality of LifeInjection Site ReactionAdverse Drug Event+1 more
Duke University 348
Post-approval studies (Phase 4)UnknownNCT05109000
What this trial is testing

Comparison of Subcutaneous Injection of Normal Saline and Bacteriostatic Saline

Who this might be right for
Injection Site IrritationInjection Site BruisingInjection Site Discomfort+2 more
Jeffrey Alan Klein, MD 32
Early research (Phase 1)Active Not RecruitingNCT06970223
What this trial is testing

Investigate if Long Acting Cabotegravir (CAB) and Lenacapavir (LEN) Injections Are Tolerable and Acceptable When Administered to Healthy Adults Without HIV

Who this might be right for
HIV Infections
ViiV Healthcare 65
Not applicableStudy completedNCT05157191
What this trial is testing

Safety of Pediatric COVID-19 Vaccination

Who this might be right for
PainInjection Site ReactionAdverse Drug Event
Duke University 299
Load More Results